Integrated approaches – Investing in efficient IBD treatment, enabling innovation in patient care delivery

EU must address barriers to continuous off-patent innovation… 23 February 2021 EU Pharma strategy provides unique moment to establish a regulatory…
2022 Health at a Glance Report highlights the need to… 5 December 2022 Over the last two years, major crises have had dramatic…
Off-patent medicines ready to drive pharma policy reform for… 15 June 2023 The EU has initiated a major overhaul of EU pharma…
Scientific advice for continuous innovation in known… 5 May 2022 Open